BHVNBiohaven Ltd.

$1B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$183M

Net Income

-$180M

EPS (Diluted)

$-2.20

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$103M

Free Cash Flow

-$103M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$419M

Total Liabilities

$117M

Stockholders' Equity

$301M

Cash & Equivalents

$183M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$183M	-$78M	-135.6%
Net Income	-$180M	-$70M	-154.6%

BHVN Q1 2024 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena